home / openregs

documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

comment_end_date
A FULL UTC INSTANT, not a calendar date, despite the column name: '2026-08-29T03:59:59Z' is 11:59:59 PM EASTERN on 2026-08-28. Federal comment periods close at 11:59:59 PM Eastern, so the UTC calendar date is ONE DAY LATER than the official deadline on every end-of-day close — 444,689 of the 444,690 populated rows (measured 2026-09-06). Convert to America/New_York before presenting a deadline, and compare with julianday(comment_end_date) > julianday('now'): a plain > datetime('now') is a TEXT comparison between two different formats and keeps already-closed dockets matching for up to ~20 hours. The sibling column on open_comments.documents WAS corrected to an Eastern calendar date (queue #498); this one is unchanged and still an instant — the two databases do not agree on grain. (queue #644)
comment_start_date
A FULL UTC INSTANT, not a calendar date, despite the column name — same grain as comment_end_date on this table. Convert to America/New_York before presenting it. (queue #644)

29 rows where docket_id = "FDA-2019-P-6049" sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

posted_year 2

  • 2020 27
  • 2019 2

document_type 2

  • Supporting & Related Material 26
  • Other 3

agency_id 1

  • FDA 29
id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2019-P-6049-0030 FDA Request that the FDA require that any abbreviated new drug application (ANDA) for a generic version of APOKYN seek approval of both the drug and device constituent parts of APOKYN FDA-2019-P-6049 Response Letter from FDA CDER to US WorldMeds, LLC Other Agency Response 2020-05-21T04:00:00Z 2020 5 2020-05-21T04:00:00Z   2020-05-21T20:19:46Z   0 0 0900006484664570
FDA-2019-P-6049-0014 FDA Request that the FDA require that any abbreviated new drug application (ANDA) for a generic version of APOKYN seek approval of both the drug and device constituent parts of APOKYN FDA-2019-P-6049 Exhibit 12 re Citizen Petition from US WorldMeds, LLC Supporting & Related Material Background Material 2020-01-07T05:00:00Z 2020 1     2020-01-07T20:40:13Z   0 0 0900006484251fe6
FDA-2019-P-6049-0024 FDA Request that the FDA require that any abbreviated new drug application (ANDA) for a generic version of APOKYN seek approval of both the drug and device constituent parts of APOKYN FDA-2019-P-6049 Exhibit 22 re Citizen Petition from US WorldMeds, LLC Supporting & Related Material Background Material 2020-01-07T05:00:00Z 2020 1     2020-01-07T20:42:51Z   0 0 0900006484252002
FDA-2019-P-6049-0028 FDA Request that the FDA require that any abbreviated new drug application (ANDA) for a generic version of APOKYN seek approval of both the drug and device constituent parts of APOKYN FDA-2019-P-6049 Exhibit 26 re Citizen Petition from US WorldMeds, LLC Supporting & Related Material Background Material 2020-01-07T05:00:00Z 2020 1     2020-01-07T20:43:57Z   0 0 0900006484252006
FDA-2019-P-6049-0008 FDA Request that the FDA require that any abbreviated new drug application (ANDA) for a generic version of APOKYN seek approval of both the drug and device constituent parts of APOKYN FDA-2019-P-6049 Exhibit 6 re Citizen Petition from US WorldMeds, LLC Supporting & Related Material Background Material 2020-01-07T05:00:00Z 2020 1     2020-01-07T20:33:41Z   0 0 0900006484251cf8
FDA-2019-P-6049-0025 FDA Request that the FDA require that any abbreviated new drug application (ANDA) for a generic version of APOKYN seek approval of both the drug and device constituent parts of APOKYN FDA-2019-P-6049 Exhibit 23 re Citizen Petition from US WorldMeds, LLC Supporting & Related Material Background Material 2020-01-07T05:00:00Z 2020 1     2020-01-07T20:43:06Z   0 0 0900006484252003
FDA-2019-P-6049-0020 FDA Request that the FDA require that any abbreviated new drug application (ANDA) for a generic version of APOKYN seek approval of both the drug and device constituent parts of APOKYN FDA-2019-P-6049 Exhibit 18 re Citizen Petition from US WorldMeds, LLC Supporting & Related Material Background Material 2020-01-07T05:00:00Z 2020 1     2020-01-07T20:41:49Z   0 0 0900006484251ffe
FDA-2019-P-6049-0022 FDA Request that the FDA require that any abbreviated new drug application (ANDA) for a generic version of APOKYN seek approval of both the drug and device constituent parts of APOKYN FDA-2019-P-6049 Exhibit 20 re Citizen Petition from US WorldMeds, LLC Supporting & Related Material Background Material 2020-01-07T05:00:00Z 2020 1     2020-01-07T20:42:21Z   0 0 0900006484252000
FDA-2019-P-6049-0004 FDA Request that the FDA require that any abbreviated new drug application (ANDA) for a generic version of APOKYN seek approval of both the drug and device constituent parts of APOKYN FDA-2019-P-6049 Exhibit 2 re Citizen Petition from US WorldMeds, LLC Supporting & Related Material Background Material 2020-01-07T05:00:00Z 2020 1     2020-01-07T20:32:44Z   0 0 0900006484251cf4
FDA-2019-P-6049-0027 FDA Request that the FDA require that any abbreviated new drug application (ANDA) for a generic version of APOKYN seek approval of both the drug and device constituent parts of APOKYN FDA-2019-P-6049 Exhibit 25 re Citizen Petition from US WorldMeds, LLC Supporting & Related Material Background Material 2020-01-07T05:00:00Z 2020 1     2020-01-07T20:43:39Z   0 0 0900006484252005
FDA-2019-P-6049-0018 FDA Request that the FDA require that any abbreviated new drug application (ANDA) for a generic version of APOKYN seek approval of both the drug and device constituent parts of APOKYN FDA-2019-P-6049 Exhibit 16 re Citizen Petition from US WorldMeds, LLC Supporting & Related Material Background Material 2020-01-07T05:00:00Z 2020 1     2020-01-07T20:41:18Z   0 0 0900006484251fea
FDA-2019-P-6049-0010 FDA Request that the FDA require that any abbreviated new drug application (ANDA) for a generic version of APOKYN seek approval of both the drug and device constituent parts of APOKYN FDA-2019-P-6049 Exhibit 8 re Citizen Petition from US WorldMeds, LLC Supporting & Related Material Background Material 2020-01-07T05:00:00Z 2020 1     2020-01-07T20:34:08Z   0 0 0900006484251fe2
FDA-2019-P-6049-0013 FDA Request that the FDA require that any abbreviated new drug application (ANDA) for a generic version of APOKYN seek approval of both the drug and device constituent parts of APOKYN FDA-2019-P-6049 Exhibit 11 re Citizen Petition from US WorldMeds, LLC Supporting & Related Material Background Material 2020-01-07T05:00:00Z 2020 1     2020-01-07T20:39:55Z   0 0 0900006484251fe5
FDA-2019-P-6049-0023 FDA Request that the FDA require that any abbreviated new drug application (ANDA) for a generic version of APOKYN seek approval of both the drug and device constituent parts of APOKYN FDA-2019-P-6049 Exhibit 21 re Citizen Petition from US WorldMeds, LLC Supporting & Related Material Background Material 2020-01-07T05:00:00Z 2020 1     2020-01-07T20:42:36Z   0 0 0900006484252001
FDA-2019-P-6049-0003 FDA Request that the FDA require that any abbreviated new drug application (ANDA) for a generic version of APOKYN seek approval of both the drug and device constituent parts of APOKYN FDA-2019-P-6049 Exhibit 1 re Citizen Petition from US WorldMeds, LLC Supporting & Related Material Background Material 2020-01-07T05:00:00Z 2020 1     2020-01-07T20:32:31Z   0 0 0900006484251cf3
FDA-2019-P-6049-0016 FDA Request that the FDA require that any abbreviated new drug application (ANDA) for a generic version of APOKYN seek approval of both the drug and device constituent parts of APOKYN FDA-2019-P-6049 Exhibit 14 re Citizen Petition from US WorldMeds, LLC Supporting & Related Material Background Material 2020-01-07T05:00:00Z 2020 1     2020-01-07T20:40:44Z   0 0 0900006484251fe8
FDA-2019-P-6049-0015 FDA Request that the FDA require that any abbreviated new drug application (ANDA) for a generic version of APOKYN seek approval of both the drug and device constituent parts of APOKYN FDA-2019-P-6049 Exhibit 13 re Citizen Petition from US WorldMeds, LLC Supporting & Related Material Background Material 2020-01-07T05:00:00Z 2020 1     2020-01-07T20:40:28Z   0 0 0900006484251fe7
FDA-2019-P-6049-0021 FDA Request that the FDA require that any abbreviated new drug application (ANDA) for a generic version of APOKYN seek approval of both the drug and device constituent parts of APOKYN FDA-2019-P-6049 Exhibit 19 re Citizen Petition from US WorldMeds, LLC Supporting & Related Material Background Material 2020-01-07T05:00:00Z 2020 1     2020-01-07T20:42:05Z   0 0 0900006484251fff
FDA-2019-P-6049-0005 FDA Request that the FDA require that any abbreviated new drug application (ANDA) for a generic version of APOKYN seek approval of both the drug and device constituent parts of APOKYN FDA-2019-P-6049 Exhibit 3 re Citizen Petition from US WorldMeds, LLC Supporting & Related Material Background Material 2020-01-07T05:00:00Z 2020 1     2020-01-07T20:32:56Z   0 0 0900006484251cf5
FDA-2019-P-6049-0019 FDA Request that the FDA require that any abbreviated new drug application (ANDA) for a generic version of APOKYN seek approval of both the drug and device constituent parts of APOKYN FDA-2019-P-6049 Exhibit 17 re Citizen Petition from US WorldMeds, LLC Supporting & Related Material Background Material 2020-01-07T05:00:00Z 2020 1     2020-01-07T20:41:34Z   0 0 0900006484251ffd
FDA-2019-P-6049-0026 FDA Request that the FDA require that any abbreviated new drug application (ANDA) for a generic version of APOKYN seek approval of both the drug and device constituent parts of APOKYN FDA-2019-P-6049 Exhibit 24 re Citizen Petition from US WorldMeds, LLC Supporting & Related Material Background Material 2020-01-07T05:00:00Z 2020 1     2020-01-07T20:43:22Z   0 0 0900006484252004
FDA-2019-P-6049-0007 FDA Request that the FDA require that any abbreviated new drug application (ANDA) for a generic version of APOKYN seek approval of both the drug and device constituent parts of APOKYN FDA-2019-P-6049 Exhibit 5 re Citizen Petition from US WorldMeds, LLC Supporting & Related Material Background Material 2020-01-07T05:00:00Z 2020 1     2020-01-07T20:33:27Z   0 0 0900006484251cf7
FDA-2019-P-6049-0006 FDA Request that the FDA require that any abbreviated new drug application (ANDA) for a generic version of APOKYN seek approval of both the drug and device constituent parts of APOKYN FDA-2019-P-6049 Exhibit 4 re Citizen Petition from US WorldMeds, LLC Supporting & Related Material Background Material 2020-01-07T05:00:00Z 2020 1     2020-01-07T20:33:08Z   0 0 0900006484251cf6
FDA-2019-P-6049-0017 FDA Request that the FDA require that any abbreviated new drug application (ANDA) for a generic version of APOKYN seek approval of both the drug and device constituent parts of APOKYN FDA-2019-P-6049 Exhibit 15 re Citizen Petition from US WorldMeds, LLC Supporting & Related Material Background Material 2020-01-07T05:00:00Z 2020 1     2020-01-07T20:41:02Z   0 0 0900006484251fe9
FDA-2019-P-6049-0012 FDA Request that the FDA require that any abbreviated new drug application (ANDA) for a generic version of APOKYN seek approval of both the drug and device constituent parts of APOKYN FDA-2019-P-6049 Exhibit 10 re Citizen Petition from US WorldMeds, LLC Supporting & Related Material Background Material 2020-01-07T05:00:00Z 2020 1     2020-01-07T20:39:38Z   0 0 0900006484251fe4
FDA-2019-P-6049-0009 FDA Request that the FDA require that any abbreviated new drug application (ANDA) for a generic version of APOKYN seek approval of both the drug and device constituent parts of APOKYN FDA-2019-P-6049 Exhibit 7 re Citizen Petition from US WorldMeds, LLC Supporting & Related Material Background Material 2020-01-07T05:00:00Z 2020 1     2020-01-07T20:33:53Z   0 0 0900006484251fe1
FDA-2019-P-6049-0011 FDA Request that the FDA require that any abbreviated new drug application (ANDA) for a generic version of APOKYN seek approval of both the drug and device constituent parts of APOKYN FDA-2019-P-6049 Exhibit 9 re Citizen Petition from US WorldMeds, LLC Supporting & Related Material Background Material 2020-01-07T05:00:00Z 2020 1     2020-01-07T20:39:22Z   0 0 0900006484251fe3
FDA-2019-P-6049-0001 FDA Request that the FDA require that any abbreviated new drug application (ANDA) for a generic version of APOKYN seek approval of both the drug and device constituent parts of APOKYN FDA-2019-P-6049 Citizen Petition from US WorldMeds, LLC Other Citizen Petition 2019-12-30T05:00:00Z 2019 12 2019-12-30T05:00:00Z   2020-05-21T20:20:07Z   0 0 0900006484258f6c
FDA-2019-P-6049-0002 FDA Request that the FDA require that any abbreviated new drug application (ANDA) for a generic version of APOKYN seek approval of both the drug and device constituent parts of APOKYN FDA-2019-P-6049 Acknowledgment Letter from FDA DMS to US WorldMeds, LLC Other Acknowledgement Letter/Receipt 2019-12-30T05:00:00Z 2019 12 2019-12-30T05:00:00Z   2019-12-30T17:48:55Z   0 0 0900006484258f70

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;
Powered by Datasette · Queries took 2.719ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API · Privacy